This guide covers the 15 mg dose specifically: what it is, how you reach the maximum strength, the side effects reported at this dose, and why higher is not automatically better. It draws on the UK Summary of Product Characteristics, the NHS and NICE.
What the 15 mg dose is
Mounjaro 15 mg delivers 15 mg of tirzepatide per weekly dose from its own pre-filled KwikPen 4. It is both the maximum dose and the highest of the three recommended maintenance doses, alongside 5 mg and 10 mg 1. The SmPC is explicit that the maximum is 15 mg once weekly 1.
Being the maximum has a clear meaning: there is no licensed dose above it, so 15 mg is the ceiling of the titration. It is a genuine maintenance dose, not an intermediate step like 12.5 mg, so people who need it can settle there long term 1.
Our Mounjaro dose guide sets out the whole schedule, and this page focuses on what is distinctive about 15 mg as the top of the range.
The way the medicine works does not change at 15 mg: tirzepatide is a dual GIP and GLP-1 receptor agonist that reduces hunger, increases fullness and slows stomach emptying at every strength 1. What a higher maintenance dose offers is a stronger version of that effect for people who need more than a lower dose provides, balanced against a somewhat higher chance of side effects 12. So 15 mg is not a different treatment, just the top of the same dose range.
How you reach the maximum strength
You reach 15 mg by climbing the full schedule: 2.5 mg for four weeks, then 5 mg, 7.5 mg, 10 mg, 12.5 mg and finally 15 mg, with each 2.5 mg increase made after a minimum of four weeks at the current dose, if needed and tolerated 1. So 15 mg is typically reached several months into treatment at the earliest, depending on how the steps go.
There is no requirement to reach the maximum. The aim is the lowest dose that works for you, and many people settle at 5 or 10 mg without going higher 1. The climb to 15 mg happens only when lower doses are not delivering enough and the higher dose is tolerated. Our article on why side effects sometimes return when you increase the dose covers the step-up experience.
You inject 15 mg once a week, on the same day where you can, rotating the site, with the same missed-dose rules as every other strength 1.
Side effects at 15 mg
The side effects at 15 mg are the same gastrointestinal ones, and the trials report 15 mg-specific figures. In the pooled weight management studies, at 15 mg nausea was reported by about 28.0 percent of people and any gastrointestinal disorder by about 55.6 percent, compared with 8.5 and 29.7 percent on placebo 2. Most were mild or moderate and decreased over time 2.
Discontinuation because of a gut side effect was highest at 15 mg among the studied doses, at about 4.3 percent, compared with 1.9 percent at 5 mg and 3.3 percent at 10 mg, which fits the pattern that side effects and stopping for them tend to rise with dose 2. So the maximum strength is, for most people, a little more demanding to tolerate than lower doses 2.
The serious cautions are unchanged at any strength: acute pancreatitis, gallbladder problems and dehydration from gut effects, with persistent severe abdominal pain needing immediate attention 3. Our full side effects guide covers what is normal and what is not.
| At 15 mg (weight management trials) | Figure |
|---|---|
| Nausea | ~28.0% vs 8.5% placebo 2 |
| Any gastrointestinal disorder | ~55.6% vs 29.7% placebo 2 |
| Stopped due to a gut side effect | ~4.3% (vs ~1.9% at 5 mg, ~3.3% at 10 mg) 2 |
| Dose position | Maximum dose; highest maintenance dose 1 |
Why higher is not automatically better
It is tempting to see the maximum dose as the goal, but that is the wrong frame. The SmPC's recommended maintenance doses are 5, 10 and 15 mg, and the right one is the lowest that gives you a good response with tolerable side effects 1. Reaching 15 mg is worthwhile only when lower doses have not delivered enough 1.
The trade-off is real: side effects and the chance of stopping for them are highest at 15 mg among the studied doses 2. So pushing to the maximum when a lower dose is already working can mean more side effects for no extra benefit. NICE's six-month checkpoint, at least 5 percent weight loss on the highest tolerated dose, is the frame for judging whether your dose is doing its job 5.
If 15 mg is your highest tolerated dose and it is delivering, that is a valid place to be. If 15 mg still is not enough, there is no licensed higher dose, so the conversation shifts to whether tirzepatide is the right treatment for you, which is covered in our guide on recognising when GLP-1 treatment is not right for you.
There is a useful way to picture the dose range. The maintenance doses, 5, 10 and 15 mg, are options along a line, with 7.5 mg and 12.5 mg as the rungs between them 1. Reaching the top of that line is not a milestone to aim for; it is simply where some people end up when lower doses are not enough and they tolerate the climb. Plenty of people get a good result well below 15 mg, and for them stopping the climb early is exactly right 1.
Living on the maximum dose
Once established on 15 mg, the gut side effects that were strongest during the climb tend to have eased, since the SmPC notes they peak around dose increases and decrease over time 2. The weekly routine, same day, fresh site, pen in the fridge until use, becomes settled 1.
Ongoing review still matters at the maximum dose. Treatment continues to be framed as an adjunct to diet and activity, and appetite returns if it stops, so the habits built on 15 mg are what protect progress 62. The contraceptive and oral-medicine interactions apply at 15 mg as at any dose, so a barrier or non-oral contraceptive method is advised around dose changes 3.
If side effects flare unexpectedly while settled on 15 mg, or new symptoms appear, that is worth raising rather than assuming it is normal, and persistent severe abdominal pain needs immediate attention 3.
Being at the maximum dose does not change the fundamentals of how the medicine is used. It is still an adjunct to diet and activity, still reviewed for whether it is working, and still a prescription-only medicine assessed individually 65. The main practical difference at 15 mg is simply that there is no higher dose to move to, so if your response or tolerance changes, the conversation is about staying, adjusting your wider plan, or whether the treatment remains right for you, rather than about going up 1.
What to discuss with your prescriber
At or approaching 15 mg, useful things to raise are how you are tolerating it, whether the step up from 12.5 mg has settled, and whether the maximum dose is genuinely needed for your response 1. If you take a sulphonylurea or insulin for diabetes, those doses may need adjusting to reduce the risk of low blood sugar 3.
If 15 mg is not delivering, the honest conversation is about whether to continue rather than how to go higher, since there is no licensed dose above it 1. Obtain Mounjaro only from a registered pharmacy after a clinical assessment, and report side effects through the Yellow Card scheme 3.
Frequently asked questions
Is 15 mg the highest dose of Mounjaro?
Yes. The SmPC states the maximum dose is 15 mg once weekly, and it is the highest of the three recommended maintenance doses (5, 10 and 15 mg) 1. There is no licensed dose above 15 mg, so it is the ceiling of the titration 1.What are the side effects of Mounjaro 15 mg?
Mainly gastrointestinal. In the weight management trials, nausea at 15 mg was reported by around 28 percent of people and any gut disorder by about 55.6 percent, mostly mild to moderate 2. Discontinuation for a gut side effect was highest at 15 mg, about 4.3 percent, fitting the pattern that effects rise with dose 2. The serious cautions are unchanged 3.Should everyone aim for 15 mg?
No. The aim is the lowest dose that works for you, and many people do well on 5 or 10 mg 1. Side effects are highest at 15 mg among the studied doses, so reaching the maximum is worthwhile only when lower doses are not enough 2. NICE's six-month checkpoint of at least 5 percent weight loss is the frame for judging your dose 5.What if 15 mg is not enough?
There is no licensed dose above 15 mg, so the conversation shifts from going higher to whether tirzepatide is the right treatment for you 1. That is a discussion to have with your prescriber, taking into account how you have responded and tolerated it, and our guide on recognising when GLP-1 treatment is not right for you may help 1.How long does it take to reach 15 mg?
Typically several months at the earliest, because you climb from 2.5 mg through 5, 7.5, 10 and 12.5 mg, with at least four weeks at each step before increasing 1. There is no requirement to reach 15 mg; the climb happens only if lower doses are not enough and the higher one is tolerated 1.Is 15 mg more effective than lower doses?
A higher dose can deliver more for people who need it, but it is not automatically better, and side effects are highest at 15 mg among the studied doses 2. The recommended maintenance doses are 5, 10 and 15 mg, and the aim is the lowest that gives a good response with tolerable side effects 1. NICE judges whether your dose is working at the six-month checkpoint of at least 5 percent weight loss 5.Your next step
Mounjaro 15 mg is the maximum strength and the highest maintenance dose, reached by climbing the full titration over several months. Its side effects are the usual gut ones, a little more common than at lower doses, the serious cautions are unchanged, and the maximum is not a goal in itself: the right dose is the lowest that gives you a good response with tolerable side effects.
If you are on or approaching 15 mg, talk to your prescriber about how you are tolerating it and whether the maximum is genuinely needed for your response. If it is not enough, the discussion is about whether to continue rather than going higher. Obtain Mounjaro only from a registered pharmacy, and report side effects through the Yellow Card scheme. Reaching the maximum is not a goal to chase, and many people get a good result on a lower maintenance dose they tolerate more comfortably.
Disclaimer
This guide is for general information only and does not constitute medical advice, diagnosis or treatment. The information here describes general clinical context based on UK regulatory sources cited above; it is not a recommendation for any specific medicine or treatment, which can only be made by a prescriber following individual assessment.
If you are considering treatment, speak to your GP or pharmacist, or arrange a consultation with a Cloud Pharmacy clinician. Prescription-only medicines are issued only after clinical assessment and where appropriate.
If you experience side effects from any medicine, you can report them through the Yellow Card scheme at yellowcard.mhra.gov.uk.
